Results 101 to 110 of about 1,091,046 (168)

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma. [PDF]

open access: yesJ Immunother Cancer
Li HL   +28 more
europepmc   +1 more source

Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohort. [PDF]

open access: yesTher Adv Musculoskelet Dis
Costi S   +11 more
europepmc   +1 more source

Management of Severe Congenital Protein C Deficiency with Continuous Subcutaneous Infusion via Insulin Pump: A Pediatric Case Report. [PDF]

open access: yesChildren (Basel)
Gentile A   +8 more
europepmc   +1 more source

Etoposide Hypersensitivity Reactions in Pediatric Oncology: Understanding Mechanisms and Optimizing Management. [PDF]

open access: yesCancers (Basel)
Filippo M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy